Recall D-0360-2022
Description: Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03), Rx only, MFG: Ascend Labs, LLC, Montvale, NJ 07645
Recall D-0360-2022 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0360-2022 |
| Event ID | 89322 |
| Distribution | Product was distributed to two direct accounts in MI and PA. |
| Quantity | a) 716 bottles/ 1432 capsules b) 223 blister packs/ 466 capsules |
| Recall Reason | Failed Impurities/Degradation Specifications |
| Drug Classification | Class II |
| Drug Code Info | 20220112 |
| Recall Initiation Date | 20211229 |
| Report Date | 20220112 |
| Classification Date | 20220105 |
| Address | 625 Kolter Dr Ste 4 Indiana, PA 15701-3571 United States |
| Recalling Firm | RemedyRepack Inc. |
| Initial Notification | Letter |
| Similar To |